Discutez avec Ed

Autres

Rejoignez notre

EN

Retour



healthcare: biotechActualités

Pour vous Marchés Économie Technologie et IA Cryptomonnaie Énergie Santé Hong Kong et Chine Finance

Pharmacie

Biotechnologie

Services de santé

Dispositifs médicaux

Skye Bioscience to acquire Redx Pharma in $125M merger creating Fibrx

Skye Bioscience to acquire Redx Pharma in $125M merger creating Fibrx

Aug 14 2026, 14:03

Tenax Therapeutics plunges 85% as Phase 3 trial misses endpoints

Tenax Therapeutics plunges 85% as Phase 3 trial misses endpoints

Aug 12 2026, 23:30

NeOnc's NEO100 hits 48.9% six-month PFS in mutant glioma trial

NeOnc's NEO100 hits 48.9% six-month PFS in mutant glioma trial

Aug 12 2026, 14:03

Silence Therapeutics prices $175M offering to extend siRNA cash runway

Silence Therapeutics prices $175M offering to extend siRNA cash runway

Aug 12 2026, 04:04

Legend Biotech posts first profitable quarter as CARVYKTI sales jump 50%

Legend Biotech posts first profitable quarter as CARVYKTI sales jump 50%

Aug 11 2026, 17:08

Replimune stock surges 223% as FDA approves RP1 melanoma therapy

Replimune stock surges 223% as FDA approves RP1 melanoma therapy

Aug 10 2026, 15:34

Two gene-editing trial deaths in China expose oversight gaps

Two gene-editing trial deaths in China expose oversight gaps

Aug 07 2026, 04:38

Biogen closes RayThera deal adding Phase 1 immunology assets

Biogen closes RayThera deal adding Phase 1 immunology assets

Aug 06 2026, 22:31

FDA clears Replimune's melanoma drug after two rejections, 10-3 vote

FDA clears Replimune's melanoma drug after two rejections, 10-3 vote

Aug 06 2026, 20:39

Tarsus to buy Alkeus for $800 million in retina push

Tarsus to buy Alkeus for $800 million in retina push

Aug 06 2026, 12:35

Iovance posts record $99M Q2 revenue as Amtagvi demand triples awareness

Iovance posts record $99M Q2 revenue as Amtagvi demand triples awareness

Aug 06 2026, 11:36

Alphamab licenses JSKN016 to Pathos AI in $2.1 billion deal

Alphamab licenses JSKN016 to Pathos AI in $2.1 billion deal

Aug 04 2026, 01:02

BioNTech names Sobi's Oelkers as CEO, succeeding Sahin by 2027

BioNTech names Sobi's Oelkers as CEO, succeeding Sahin by 2027

Aug 03 2026, 10:24

Grail trades near $70 after Galleri trial failure erases $2.2B

Grail trades near $70 after Galleri trial failure erases $2.2B

Aug 01 2026, 17:48

GSK, Relation Therapeutics sign $110 million AI drug discovery deal

GSK, Relation Therapeutics sign $110 million AI drug discovery deal

Jul 30 2026, 09:53

J&J joins in vivo CAR-T race as pharma bets $14B on technology

J&J joins in vivo CAR-T race as pharma bets $14B on technology

Jul 29 2026, 21:52

Viking Therapeutics advances 3 obesity trials with $502M cash runway

Viking Therapeutics advances 3 obesity trials with $502M cash runway

Jul 29 2026, 20:34

uniQure targets Q3 2026 BLA submission after FDA accelerated-approval alignment

uniQure targets Q3 2026 BLA submission after FDA accelerated-approval alignment

Jul 29 2026, 18:08

Allogene's cema-cel clears 58% MRD rate, wins FDA RMAT and Fast Track

Allogene's cema-cel clears 58% MRD rate, wins FDA RMAT and Fast Track

Jul 29 2026, 12:54

Ocugen wins FDA RMAT designation for OCU410 targeting 2M GA patients

Ocugen wins FDA RMAT designation for OCU410 targeting 2M GA patients

Jul 29 2026, 11:20

Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Comparaison de cryptomonnaies

Markets

News

AI & Technology

Conditions d’utilisation Politique de confidentialité Plan du site

© 2026 Edgen fonctionné par